 |
Articles: Marketing/Media/ROI |
Covidien Completes Sale of Sleep Diagnostics Product Line
Covidien, 09/28/09
Teva Provides Update On Generic Evista Litigation
Teva Pharmaceutical Industries, 09/25/09
Free full text
European Commission Grants Conditional Marketing Authorization to Cayston for the Treatment of Chronic Pulmonary Infections Due to Pseudomonas Aeruginosa in Patients with Cystic Fibrosis
Gilead, 09/24/09
Free full text
New Service Facility Greatly Increases Support and Cuts Time to Market for American Customers
b3c newswire, 09/23/09 Cell Therapeutics Added to the NASDAQ OMX Global Biotechnology Index
Cell Therapeutics, 09/23/09
Free full text
Strategic Outsourcing of Media Design and Cell Culture Media Manufacturing
BioPharm, 09/22/09
Free full text
EMR sales hit 7-year low in 2008, KLAS says
Canadian Healthcare Technology, 09/21/09
Free full text
Bristol-Myers Squibb Company Announces Sale to Taisho Pharmaceutical Co Ltd., of Its OTC Assets in Asia Pacific and Shares in PT Bristol-Myers Squibb Indonesia Tbk
Bristol Myers-Squibb Company, 09/17/09
Free full text
Boston Scientifics Urology/Gynecology Business Forms Marketing Alliance with Bladder Health Network
Boston Scientific, 09/15/09
Free full text
Astellas Announces New Vice President of Marketing
Astellas, 09/11/09
Free full text
Par Pharmaceutical Receives Final Approval To Market Generic Starlix
Par Pharmaceutical, 09/11/09 MediGene AG Receives Marketing Authorization for Veregen in Germany
MediGene, 09/10/09
Free full text
Salix Receives FDA Marketing Approval for Metozolv
Salix Pharmaceuticals, 09/09/09
Free full text
Supply Plan of "Tamiflu" Anti-influenza Drug
Chugai Pharmaceutical Co., 09/08/09
Free full text
Merck Launches SAFLUTAN in International Markets
Merck & Co., 09/04/09
Free full text
Bayer Acquires Two Prescription Dermatology Product Lines from SkinMedica in the U.S. -- Bayer subsidiary Intendis expands presence in the U.S. / Asset purchase agreement signed for marketed prescription products Desonate and NeoBenz Micro
BayNews International, 09/03/09
Free full text
Mylan Launches First Generic Version of Xopenex Inhalation Solution, 0.25%
Mylan, 09/02/09 Abbott Launches Next-Generation XIENCE PRIME Drug Eluting Stent in International Markets
Abbott, 09/01/09 BTG Sells HySolv Technology to Major Pharmaceutical Company
BTG, 08/31/09
Free full text
Mylan Begins Marketing First Generic Version of BenzaClin Acne Treatment
Mylan, 08/28/09
|
|
Receive free subspecialty "5-minute updates" via email
|
|
Indexed Journals: U.S.Pharmacist, FDA Drug Alerts, Pharmiweb
more...
|
234 Available Pages
|
|
